In The News

Getting on Target for Alzheimer’s

Biogen Reports Drug Effective in Slowing Alzheimer’s Disease: ‘A Milestone Achievement’

Episode 90: Biogen's big reveal, hot takes on Alzheimer's, & the science of one-eyed sheep

Financial Times – Alzheimer’s drug revival gives hope to millions — and investors

STAT – Biogen’s good news on aducanumab could ‘open the floodgates’ for Alzheimer’s drugs

The Big Biz Show – Interview with Dr. Elliot Goldstein

European Biopharmaceutical Review July 2019

Alzheimer’s Solution Shows Promise after Big Pharma’s Cure Fails

Ending Parkinson’s disease: The path is getting shorter

Alzheimer’s Disease is a ‘Double-Prion Disorder,’ Study Shows